Campbell David Alan
Insider CIK 1864158 · JANX President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics, Inc. | G Gift | 2026-07-31 | 2026-07-31 | 123,840 | — | $0 | 264,742 | SEC↗ |
| JANX Janux Therapeutics, Inc. | G Gift | 2026-07-31 | 2026-07-31 | 123,840 | — | $0 | 264,742 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2026-07-08 | 2026-07-10 | 7,000 | — | $0 | 697,550 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2026-07-08 | 2026-07-10 | 7,000 | $4.21 | $29.5K | 388,582 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-02 | 338,100 | — | $0 | 338,100 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2026-01-02 | 2026-01-02 | 8,072 | $13.73 | $110.8K | 284,982 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award | 2026-01-02 | 2026-01-02 | 96,600 | — | $0 | 381,582 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2025-01-07 | 2025-01-08 | 5,000 | $60.00 | $300.0K | 293,054 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 283,500 | — | $0 | 283,500 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award | 2025-01-02 | 2025-01-03 | 81,000 | — | $0 | 298,054 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-12-24 | 2024-12-27 | 25,000 | $56.19 | $1.40M | 217,054 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-12-03 | 2024-12-03 | 15,000 | $67.00 | $1.00M | 242,054 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-11-25 | 2024-11-27 | 18,281 | $51.43 | $940.2K | 263,773 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-11-25 | 2024-11-27 | 6,719 | $52.04 | $349.7K | 257,054 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-28 | 2024-10-30 | 11,103 | $53.94 | $598.9K | 282,054 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-28 | 2024-10-30 | 13,897 | $53.22 | $739.6K | 293,157 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-27 | 2024-09-27 | 795 | $47.84 | $38.0K | 307,054 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-27 | 2024-09-27 | 5,248 | $46.86 | $245.9K | 307,849 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-27 | 2024-09-27 | 18,957 | $46.09 | $873.7K | 313,097 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2024-01-02 | 2024-01-03 | 356,500 | — | $0 | 356,500 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 310,000 | — | $0 | 310,000 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 354,250 | — | $0 | 354,250 | SEC↗ |